Prosoria Psoriasis Treatment
NDC 71573-102, Salicylic Acid, gel, from Nuvothera, Inc..
- Product NDC
- 71573-102
- Status
- Listed
- Labeler
- Nuvothera, Inc.
- Dosage form
- GEL
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M032
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71573-102 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SALICYLIC ACID1.77 g/59mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71573-102-01 | 71573010201 | 59 mL in 1 BOTTLE, PLASTIC (71573-102-01) |
| 71573-102-08 | 71573010208 | 118 mL in 1 BOTTLE, PLASTIC (71573-102-08) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 71573-102 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71573-102 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71573-102. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.